Fresenius Kidney Care Executive and Leadership Team

Matthew Hulgan, the Chief Executive Officer at Fresenius Kidney Care, directs the overarching strategic vision for the organization. Overseeing the expansion of outpatient dialysis centers, the Chief Executive Officer ensures that clinical standards remain high across all facilities. This leadership role involves coordinating with the board to drive long-term growth and operational efficiency within the competitive healthcare landscape. By prioritizing patient-centered care models, Matthew Hulgan directly influences the quality of life for thousands of individuals requiring renal support. The Chief Executive Officer manages complex relationships with healthcare providers and regulatory bodies to maintain market leadership. Through rigorous oversight of national operations, the Chief Executive Officer secures the financial and clinical health of the entire network. This executive leadership ensures that the mission of providing accessible, high-quality kidney care remains the primary focus of every outpatient center under the corporate umbrella.

Ken Anna, the Chief Financial Officer at Fresenius Kidney Care, manages the fiscal health and capital allocation strategies for the organization. Overseeing the budgeting process, the Chief Financial Officer ensures that resources align with the expansion of outpatient dialysis services. This leadership role involves analyzing market trends to optimize revenue cycles and reduce operational costs across the national network. By implementing robust financial controls, Ken Anna directly impacts the sustainability of the company's clinical mission. The Chief Financial Officer collaborates with executive leadership to evaluate investment opportunities in new medical technologies and facility upgrades. Through precise financial forecasting, the Chief Financial Officer maintains the stability required to support ongoing patient care initiatives. This role demands constant vigilance over economic indicators to ensure that the organization remains a leader in the specialist hospital industry while delivering consistent value to stakeholders.

Abdellah Aitslimane, the Chief Financial Officer & Head of Support Services at Fresenius Kidney Care, directs the integration of financial planning with essential operational support functions. Overseeing the logistics and administrative infrastructure, the Chief Financial Officer & Head of Support Services ensures that outpatient centers receive the necessary resources to function efficiently. This leadership role involves streamlining internal processes to enhance the delivery of dialysis services. By optimizing support service workflows, Abdellah Aitslimane directly contributes to the operational excellence of the entire organization. The Chief Financial Officer & Head of Support Services manages the intersection of fiscal responsibility and service delivery, ensuring that every dollar spent improves the patient experience. Through strategic management of support departments, the Chief Financial Officer & Head of Support Services maintains the high standards required for specialized hospital operations, ultimately driving the company's ability to scale its life-saving services across diverse regional markets.

Maureen Bernacki, the Chief Financial Officer, Fresenius Health Partners at Fresenius Kidney Care, manages the financial strategy for the health partnerships division. Overseeing the fiscal performance of collaborative care models, the Chief Financial Officer, Fresenius Health Partners ensures that joint ventures align with the broader corporate mission of improving renal health outcomes. This leadership role involves negotiating complex partnership agreements and monitoring the financial viability of integrated care programs. By driving fiscal accountability within these partnerships, Maureen Bernacki directly supports the expansion of value-based care initiatives. The Chief Financial Officer, Fresenius Health Partners coordinates with clinical leaders to ensure that financial structures support the delivery of high-quality dialysis services. Through meticulous oversight of partnership budgets, the Chief Financial Officer, Fresenius Health Partners secures the resources necessary for long-term growth and innovation in the specialized hospital sector, ensuring that collaborative efforts remain both profitable and patient-focused.

Kira Ievleva, the Deputy Chief Financial Officer at Fresenius Kidney Care, supports the executive financial team in maintaining rigorous fiscal oversight. Overseeing the daily financial reporting and compliance activities, the Deputy Chief Financial Officer ensures that all accounting practices meet industry standards. This leadership role involves analyzing operational data to identify cost-saving opportunities within the outpatient dialysis network. By providing detailed financial insights, Kira Ievleva directly assists the Chief Financial Officer in making informed strategic decisions. The Deputy Chief Financial Officer manages the internal audit processes to ensure transparency and accuracy across all financial statements. Through the implementation of advanced financial tracking systems, the Deputy Chief Financial Officer enhances the company's ability to monitor performance metrics in real-time. This role is essential for maintaining the financial integrity of the organization, ensuring that resources are allocated effectively to support the company's mission of providing superior kidney care.

Ryan Valle, the President & Senior VP, Azura Vascular Care & , Strategic Development Care Delivery (US) at Fresenius Kidney Care, directs the growth of vascular care services and strategic development initiatives. Overseeing the expansion of specialized care delivery across the United States, the President & Senior VP, Azura Vascular Care & , Strategic Development Care Delivery (US) ensures that clinical capabilities meet the evolving needs of dialysis patients. This leadership role involves identifying new market opportunities and integrating advanced vascular procedures into the existing service portfolio. By driving strategic development, Ryan Valle directly enhances the company's competitive position in the specialist hospital market. The President & Senior VP, Azura Vascular Care & , Strategic Development Care Delivery (US) collaborates with regional teams to standardize care protocols and improve patient access. Through the execution of growth strategies, the President & Senior VP, Azura Vascular Care & , Strategic Development Care Delivery (US) ensures that the organization remains at the forefront of renal care innovation.

C. Haron, the President & Senior VP, Freseniusrx & Fresenius Medical Care (North America) at Fresenius Kidney Care, directs the pharmacy operations and regional medical care strategy. Overseeing the distribution of essential medications and clinical services across North America, the President & Senior VP, Freseniusrx & Fresenius Medical Care (North America) ensures that patients receive comprehensive support for their dialysis treatments. This leadership role involves managing the supply chain for pharmaceutical products and coordinating clinical care delivery across the continent. By optimizing pharmacy services, C. Haron directly improves the patient experience and treatment adherence. The President & Senior VP, Freseniusrx & Fresenius Medical Care (North America) collaborates with regional directors to ensure that medical care standards remain consistent and effective. Through the strategic management of these critical functions, the President & Senior VP, Freseniusrx & Fresenius Medical Care (North America) secures the company's reputation for excellence in the North American renal care market.